Gasverksgatan 1
Lund 222 29
Sweden
46 46 16 20 70
https://www.spectracure.com
Sektor(en): Healthcare
Branche: Medical Devices
Vollzeitmitarbeiter: 16
Name | Titel | Zahlen | Ausgeübt | Geburtsjahr |
---|---|---|---|---|
Dr. Masoud Khayyami Ph.D. | Interim CEO & Director | 300k | N/A | 1963 |
Mr. Henrik Ljung | Chief Financial Officer | N/A | N/A | 1958 |
Dr. Johannes Swartling Ph.D. | Chief Technology Officer | N/A | N/A | 1972 |
Ms. Mirjam Johansson | Administrative Manager | N/A | N/A | N/A |
Ms. Kristina Holst | Head of Clinical Affairs | N/A | N/A | 1967 |
SpectraCure AB (publ) engages in the development of cancer treatment system. It develops Q-PRO, a laser device; and IDOSE software with interstitial photodynamic therapy system for the treatment of prostate cancer. The company was incorporated in 2003 and is based in Lund, Sweden.
SpectraCure AB (publ)s ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.